NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
The title compound, C20H16N2O, (I), has been unwittingly obtained from the slow evaporation of a saturated solution of commercial benserazide hydro-chloride [benserazide, (II), being one of the principal therapeutic compounds used for the management of Parkinson's disease, mostly used in combination with levodopa]. The mol-ecule of (I) is composed of two planar 4-methyl-quinoline aromatic moieties [maximum deviations of 0.0104 (18) and 0.016 (2) Å], almost perpendicular to each other [dihedral angle = 89.5 (2)°], bridged by an O atom. The supra-molecular organization consists of a π-bonded chain, resulting from the stacking of mol-ecules related by inversion centres located along direction [111].
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.